Latest available resultsQuarter ended June 30, 202610-Q · August 4, 2026
Filed with the SECDAVITA INC.
DVAHealthcare
Next reportOctober 27, 2026after close · Analyst forecast 3.614 $/share
Revenue
$3.55B
▲ +5.2% vs prior year% YoY
Net income
$265.40M
▲ +33.1% vs prior year% YoY
EPS
4.02$
▲ +55.8% vs prior year% YoY
Net margin
7.5%
▲ +1.6 percentage points vs prior year pp YoY
Revenue▲ +5.2 %
Margins (% of revenue)Gross N/AOperatingNet
Net income▲ +33.1 %
EPS▲ +55.8 %
View financial tableQuarter ended June 30, 2026
| Metric | Value | Context |
|---|---|---|
| Operations | ||
| Revenue | $3.55B | |
| Gross profit | — | never filed |
| Operating income | $579.00M | 16.3 % |
| Net income | $265.40M | 7.5 % |
| R&D | — | never filed |
| EPS (diluted) | 4.02 $ | |
| Balance sheet | ||
| Assets | $17.71B | |
| Liabilities | $16.63B | |
| Equity | −$481.98M | |
| Cash | $668.96M | |
| Capital | ||
| Shares outstanding | 63.80M | as of 2026-07-31 |
| Public float | — | |